Delivered quarterly, CRM Pulse is generated
from more than 500 million Veeva CRM interactions for the
industry's most complete, timely, and accurate HCP access
data
BARCELONA, Spain, March 5,
2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today
announced Veeva CRM Pulse, a data subscription that provides
quarterly healthcare professional (HCP) access and multichannel
engagement metrics for the life sciences industry. With HCP access
data as an input for segmentation, targeting, and engagement
planning, Pulse provides immediate value for commercial operations
and data analytics teams.
Pulse is unique in giving customers HCP data that has:
- True Industry Census: Based on global usage of Veeva's
leading CRM Suite, Pulse is the most complete, timely, and accurate
data set for HCP access.
- Unmatched Coverage: Access and engagement metrics
by channel are available for more than three million HCPs across
102 specialties and 21 countries.
- Aggregated for Data Privacy: HCP metrics are segmented
and aggregated by country, specialty, and brick for data
privacy.
"Pulse is a breakthrough data product that will greatly improve
segmentation and targeting around the globe," said Peter Stark, executive vice president of Veeva
Data Cloud. "We look forward to working with our early customers to
bring the value of CRM Pulse data to their commercial
operations."
Pulse is available for license to Veeva's CRM customers today
with 2024 quarterly data covering the
United States, Canada,
Germany, United Kingdom, France, Italy, Spain,
Portugal, Austria, Switzerland, Netherlands, Belgium, Ireland, Hungary, Brazil, Mexico, Australia, New
Zealand, South Korea,
Taiwan, and Singapore. Quarterly data releases for 2025
will begin this April. Additional countries in Asia and Europe are planned for availability next
year.
Veeva CRM Pulse is part of Veeva Data Cloud, which includes
Veeva OpenData, Veeva Link, and Veeva Compass. For more
information, visit veeva.com/eu/Pulse.
About Veeva Systems
Veeva is the global leader in
cloud software for the life sciences industry. Committed to
innovation, product excellence, and customer success, Veeva serves
more than 1,000 customers, ranging from the world's largest
biopharmaceutical companies to emerging biotechs. As a Public
Benefit Corporation, Veeva is committed to balancing the interests
of all stakeholders, including customers, employees, shareholders,
and the industries it serves. For more information, visit
veeva.com/eu.
Veeva Forward-looking Statements
This release contains
forward-looking statements regarding Veeva's products and services
and the expected results or benefits from use of our products and
services. These statements are based on our current expectations.
Actual results could differ materially from those provided in this
release and we have no obligation to update such statements. There
are numerous risks that have the potential to negatively impact our
results, including the risks and uncertainties disclosed in our
filing on Form 10- Q for the period ended October 31, 2024, which you can
find here (a summary of risks which may impact our
business can be found on pages 36 and 37), and in our subsequent
SEC filings, which you can access at sec.gov.
Contact:
Meera Lakhani-Patel
Veeva Systems
+44-790-430-0698
meera.lakhani-patel@veeva.com
Logo -
https://mma.prnewswire.com/media/1488285/Veeva_Systems_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/veeva-crm-pulse-improves-segmentation-and-targeting-with-brick-level-hcp-access-data-for-21-countries-302392448.html
